Metastatic Hormone Refractory Prostate Cancer Completed Phase 1 Trials for MEDI-6469 (DB15306)

Also known as: Metastatic hormone refractory Prostate cancer / Metastatic Prostate cancer / Prostate cancer metastatic / Metastatic Prostate Carcinoma / Carcinoma of the prostate metastatic / Prostatic cancer metastatic

IndicationStatusPhase
DBCOND0036371 (Metastatic Hormone Refractory Prostate Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01303705Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate CancerTreatment